Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic safety study in acute and chronic pain
ACTRN12610000598088Phase 4Withdrawn
- Sponsor
- AFT Pharmaceuticals
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acetaminophen + ibuprofen, acetaminophen and ibuprofen in acute pain and chronic pain (3 arms), sponsored by AFT Pharmaceuticals. Primary endpoint: Safety profile compared with established safety of paracetamol and ibuprofen alone. Planned start Oct 2010; status: withdrawn.
02
Drugs
acetaminophen + ibuprofenacetaminophenibuprofen
03
Conditions
acute painchronic pain
Beyond the preview
Go deeper on ACTRN12610000598088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000598088.